medigraphic.com

2000, Number 4

<< Back Next >>

Arch Cardiol Mex 2000; 70 (4)

Evaluation of candidates for heart transplant. Indications, prognosis and patients selection

Almenar L, Morillas P, Rueda J, Roldán FJ, Osa A, Palencia M

Language: Spanish
References: 20
Page: 407-416
PDF size: 0. Kb.


Text Extraction

No abstract


REFERENCES

  1. Guidelines of the evaluation and management of heart failure report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) ACC/AHA TASK FORCE REPORT. J Am Coll Cardiol 1995; 26: 1376-1398.

  2. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285:1441-1446.

  3. Pulpón LA: Insuficiencia cardíaca: una plaga del siglo XXI. Newton 1999; 11: 3.

  4. Almenar L, Arizón JM, Ballester M, Concha M, Delgado J, Gómez MA, et al: Indicaciones actuales y evaluación preoperatoria del receptor. Retrasplante. Trasplante cardíaco. Conferencia Consenso Nacional 1996. (Concha M, Arizón JM, Crespo M, Llorens R, eds.). Barcelona: Gráficas Boada, S.L. 1996; 39-82.

  5. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ, et al: The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Official Report–1998. J Heart Lung Transplantation 1998; 17: 656-668.

  6. Almenar L: Registro Nacional de Trasplante Cardíaco. IX Informe Oficial (1984-1997). Rev Esp Cardiol 1999; 52:153-158.

  7. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive hearty failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.

  8. SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325:293-302.

  9. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al: A comparison of enalapril with hydralazine-isosorbide in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.

  10. Costanzo MR, Augustine S, Bourge R, Bristow M, O’Connell JB, Driscoll D, et al: Selection and treatment of candidates for Heart Transplantation. Circulation 1995; 92: 3593-3612.

  11. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, et al: 24Th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 1993; 22: 21-31.

  12. Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19: 48-54.

  13. Ceniceros I, Almenar L, López-Baeza JA, Cabadés A, Palencia M: Trasplante cardíaco de extrema urgencia en paciente críticos: Experiencia de una UCI médica. Med Intensiva 1996; 20: 340-344.

  14. Rheman MJ, Rheman B, Icenogle T, Christensen R, Copelan J: Diabetes and heart transplantation. J Heart Transplant 1988; 7: 356-358.

  15. Castro P, Bourge R, Jalill J, Martínez JA: Selección y evaluación de pacientes candidatos a trasplante cardíaco. Rev Esp Cardiol 1999; 52: 620-616.

  16. O’Connel JB, Bourge RC, Costanzo-Nordin M, Dricoll DJ, Morgan JP, Rose EA, et al: Cardiac transplantation:recipient selection, donor procurement and medical follow-up: a statement for health professionals from the Committee on cardiac transplantation of the Council on Clinical Cardiology, Am Heart Association. Circulation 1992; 86: 1061-1079.

  17. Loria KM, Salinger MH, Frolich TG, Arentzen CE, Alexander JC, Anderson RW: Right lower lobectomy for pulmonary infarction before orthotopic heart transplantation. J Heart Lung Transplant 1991; 10: 325-328.

  18. Bourge RC: Cardiac transplantation. (Bennett JC, Plum F, eds.). Cecil textbook of medicine. 20ª ed. Filadelfia: WB Saunders Company, 1996; 48 :360-367.

  19. Morillas P, Almenar L, Rueda J, Osa A, Martínez-Dolz L, Arnau MA, et al: Estudio sobre la toxicidad del tratamiento inmunosupresor en el trasplante cardiaco (Abstract). Latido 1999; 7: 167.

  20. Boucek MM, Novick RJ, Bennett LE, Fiol B, Keck BM, Hosenpud JD: The Registry of the International Society of Heart and Lung Transplantation: Second Official Pediatric Report-1998. J Heart Lung Transplant 1998; 17: 1141-1160.




2020     |     www.medigraphic.com